Abstract
Nomifensine pharmacokinetics were determined in healthy volunteers after the oral administration of 50 mg of the drug. Peak plasma levels of 95-177 ng/ml were attained within 1 to 4 hrs, and the apparent plasma half-lives ranged from 3.3 to 4.9 hrs. Assuming 100% bioavailability the drug has a relatively large apparent volume of distribution.
From these findings it appears that the pharmacokinetics profile of nomifensine is considerably different from those of other known antidepressants. Implications for dosages schedules are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B.: Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data. Europ. J. clin. Pharmacol. 4, 82–91 (1972a)
Alexanderson, B.: Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses-across-over study. Europ. J. clin. Pharmacol. 5, 1–10 (1972b)
Angst, J., Koukkou, M., Bleuler-Herzog, M., Martens, H.: Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin. Arch. Psychiat. Nervenkr. 219, 265–276 (1974)
Braithwaite, R. A., Widdop, B.: A specific gas-chromatographic method for the measurement of “steady-state” plasma levels of amitriptyline and nortriptyline in patients. Clin. chim. Acta 35, 461–472 (1971)
Costall, B., Kelley, D. M., Naylor, R. J.: Nomifensine: A potent dopaminergic against of antiparkinson potential. Psychopharmacologia (Berl.) 41, 153–164 (1975)
Franchin, E. A.: Ensaio clinico em 30 pacientes de una nova medicaÇÃo antidepressiva: Nomifensin. Rev. bras. clin. Ter. 2, 317–322 (1973)
Garattini, S., Morselli, P. L.: Monitoring plasma levels of tricyclic antidepressant agents: an individualized approach to depression therapy. In: Physician's guide to depression, R. F. Fieve, ed., pp. 101–130. New York: P. W. Communications Inc. Publ. 1975
Gerhards, H. J., Carenzi, A., Costa, E.: Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3′,5′-adenosine monophosphate concentrations of rat striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 49–63 (1974)
Hoffmann, I.: 8-Amino-2-methyl-4-phenyl-l,2,3,4-tetrahydroisoquinoline, a new antidepressant. Arzneimittel-Forsch. 23, 45–50 (1973)
Hunt, P., Kannengiesser, M.-H., Raynaud, J.-P.: Nomifensince: a new potent inhibitor of dopamine uptake intosynaptosomes from rat brain corpus striatum. J. Pharm. Pharmacol. 26, 370–371 (1974)
Madalena, J. C, Azavedo, O. F., Morais, M. L., Santana, R. L., Rzezinsky, P. C., Almeida, J., Lovenkront, T. S.: Uma nova substância psicotrópica antidepressiva: Nomifensin. Primeiros ensaios clinicos. Rev. bras. clin. Ter. 2, 311–316 (1973)
Morselli, P. L., Gerna, M., De Maio, D., Zanda, G., Viani, F., Garattini, S.: Pharmacokinetic studies on carbamazepine in volunteers and in epileptic patients. In: Pharmacology of anti-epileptic drugs, H. Schneider, ed. Berlin-Heidelberg-New York: Springer 1975 (in press)
Morselli, P. L., Morganti, A., Bianchetti, G., Di Salle, E., Leonetti, G., Chidsey, C. A., Zanchetti, A.: Plasma levels and pharmacokinetic studies of propranolol during chronic treatment in hypertensive patients. Europ. J. clin. Invest. 4, 347 (1974)
Pantarotto, C., Belvedere, G., Burti, L., Frigerio, A.: Mass fragmentographic determination of “steady-state” plasma levels of imipramine and desipramine in chronically treated patients. In: Proc. 2nd. Int. Symp. on Mass Spectrometry in Biochemistry and Medicine, Milan, June 24-26, 1974, A. Frigerio and N. Castagnoli, eds., Flushing, N.Y.: Spectrum Publ. 1975 (in press)
Rizzo, M., Jogan, E., Giannelli, A., Standen, S. M., Morselli, P. L.: Alcune osservazioni sulle correlazioni fra livelli plasmatici degli antidepressivi triciclici monometilati ed effetti terapeutici. Riv. sper. Freniat. 97, 837–861 (1973)
Vereczkey, L., Bianchetti, G., Rovei, V., Frigerio, A.: Gaschromatographic method for the determination of nomifensine in human plasma. J. Chromatogr. (in press, 1975)
Wagner, J. G.: Biopharmaceutics and relevant pharmacokinetics. Hamilton, Ill.: Drug Intelligence Publ. 1971
Author information
Authors and Affiliations
Additional information
Visiting Scientist from the Chemical Works of G. Richter Ltd., Budapest, Hungary.
Rights and permissions
About this article
Cite this article
Vereczkey, L., Bianchetti, G., Garattini, S. et al. Pharmacokinetics of nomifensine in man. Psychopharmacologia 45, 225–227 (1975). https://doi.org/10.1007/BF00429065
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429065